A retrospective study compared progression-free and overall survival of hyperthermic intraperitoneal chemotherapy with conventional intraperitoneal chemotherapy in patients with ovarian cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback